Daniel Christopher Rowe
2Patents
0h-index
6Co-inventors
21Inventor score
Filing activity: May 18, 2021 → May 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12146000B2 | Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11999800B2 | Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.